BDSRA awards research grants at annual conference, August 1, 1999. 

Adam Golabek, Ph.D., Institute for Basic Research, Staten Island, NY - $11,000 
“Reversibility of the CLN3 associated phenotype in vitro” 

Jonathan Cooper, Ph.D., Stanford University - $5000 
“Prevention or reversal of CLN3 by neurotrophic factors.” 
(To be matched by Natalie Fund) 

David Pearce, Ph.D., University of Rochester - $5000 
“Phenotypic comparison of retinal cell lines established from normal and CLN3 knockout mice.” 

Laura Aberg, M.D., Universtiy of Helsinki - $6600 
“Evaluation and treatment of extrapyramidal signs in Batten Disease.” 

Robert Jolly, Ph.D., Massey University - $3500 
“Mitochondrial degeneration in OCL6.” 
(Grant is to maintain sheep colony for one year) 

Svetlana Rylova, Ph.D. and Rose-Mary Boustany, M.D., Duke University - $5000 
“A human neuronal cell model for assesment of therapies for treating juvenile Batten Disease.” 

For additional information contact  BDSRA at 1-800-448-4570 or 740-927-4298 outside USA and Canada. 

Return to Home Page | BDSRA Services & Chapters | About Batten Disease | Faces of Batten | What's New? | Related Sites | Contact BDSRA | How To Join BDSRA 

BDSRA Home Page